Format

Send to

Choose Destination
Curr Opin Crit Care. 2016 Feb;22(1):80-5. doi: 10.1097/MCC.0000000000000274.

Current and future status of extracorporeal life support for respiratory failure in adults.

Author information

1
Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA.

Abstract

PURPOSE OF REVIEW:

The purpose is to review the development and current application of extracorporeal life support [ECLS, extracorporeal membrane oxygenation (ECMO)] in acute severe respiratory failure.

RECENT FINDINGS:

Extracorporeal support (ECMO) is used for acute severe respiratory failure in advanced ICUs. The current survival rate is 60-70%. Three controlled trials all demonstrated 20-30% improvement in survival compared to conventional care. Patients may now be maintained awake and ambulatory with spontaneous breathing.

SUMMARY:

ECMO is the next step in the algorithm for management of severe respiratory failure unresponsive to conventional care.

PMID:
26702599
DOI:
10.1097/MCC.0000000000000274
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center